The intertwined epidemics of human immunodeficiency virus (HIV) infection and chemical
dependency continue to be a challenge for optimal medical care delivery in the era of potent …

Context.—In British Columbia, human immunodeficiency virus (HIV)–infected persons
eligible for antiretroviral therapy may receive it free but the extent to which HIV-infected …

Context Highly active antiretroviral therapy (HAART) is often withheld from injection drug
users (IDUs) infected with the human immunodeficiency virus (HIV) based on the belief that …

To the Editor: Dr Strathdee and colleagues1 identified patient and physician characteristics
associated with antiretroviral therapy (ART) use in injection drug users (IDUs) infected with …

Abstract Background Injection drug users (IDUs) face numerous obstacles to receiving
optimal HIV care, and have been shown to underutilize antiretroviral therapy (ART). We …

Injection-drug use has become an important risk factor for infection with the human
immunodeficiency virus (HIV), and HIV infection has become well established among drug …

Context.—The US Public Health Service and the International AIDS Society–USA recently
published recommendations for antiretroviral therapy (ART) for persons infected with human …

Methods In British Columbia, all HIV-positive persons are eligible for HAART free of charge
through a province-wide drug treatment program. The Barriers to Access to Antiretroviral …

ENHANCED HUMAN IMMUNODEFICIENCY VIRUS (HIV) testing and treatment have been
proposed as a strat-egy to further decrease AIDS-related morbidity and mortality and to …

Although there are many potential reasons—such as individual differences in drug
absorption or metabolism—for the failure of highly active antiretroviral therapy (HAART) to …